Physician profile
Jack C Askins
NPI 1316039712
$1,868.72
in general payments reported to CMS, 2019-2025
17 companies · $53.03 in 2025
The $53.03 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $88.46 · 2021: $501 · 2022: $672 · 2023: $136 · 2024: $71.60 · 2025: $53.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $368.79 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $198.41 | 2021-2022 | |
| Beckman Coulter, INC. | $186.23 | 2021 | |
| Inari Medical, INC. | $161.21 | 2022 | |
| Merck Sharp & Dohme LLC | $153.68 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $140.87 | 2022-2025 | Eliquis |
| Abbott Laboratories | $134.77 | 2022-2025 | Gallant, Aveir |
| Heartflow, INC. | $126.24 | 2022 | |
| Medtronic, INC. | $121.79 | 2023 | Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $114.14 | 2021 | |
| Edwards Lifesciences Corporation | $66.53 | 2020 | |
| Pfizer INC. | $18.53 | 2022 | |
| Boston Scientific Corporation | $17.19 | 2022 | |
| Inspire Medical Systems, INC. | $16.21 | 2025 | Inspire |
| Amgen INC. | $15.30 | 2024 | Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.79 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.04 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Askins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.